Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Annals of oncology

Results: 1-25/1904

Authors: Parsa-Parsi, R Engert, A Diehl, V
Citation: R. Parsa-parsi et al., An overview of the Fourth International Symposium on Hodgkin's Disease - Recent advances in basic and clinical research, ANN ONCOL, 9, 1998, pp. 1-3

Authors: Chapman, ALN Rickinson, AB
Citation: Aln. Chapman et Ab. Rickinson, Epstein-Barr virus in Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 5-16

Authors: Kuppers, R Hansmann, ML Rajewsky, K
Citation: R. Kuppers et al., Clonality and germinal centre B-cell derivation of Hodgkin/Reed-Sternberg cells in Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 17-20

Authors: Poppema, S Potters, M Visser, L van den Berg, AM
Citation: S. Poppema et al., Immune escape mechanisms in Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 21-24

Authors: Jaffe, ES Harris, NL Diebold, J Muller-Hermelink, HK
Citation: Es. Jaffe et al., World Health Organization Classification of lymphomas: A work in progress, ANN ONCOL, 9, 1998, pp. 25-30

Authors: Rudiger, T Jaffe, ES Delsol, G deWolf-Peeters, C Gascoyne, RD Georgii, A Harris, NL Kadin, ME MacLennan, KA Poppema, S Stein, H Weiss, LE Muller-Hermelink, HK
Citation: T. Rudiger et al., Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma), ANN ONCOL, 9, 1998, pp. 31-38

Authors: Franklin, J Tesch, H Hansmann, ML Diehl, V
Citation: J. Franklin et al., Lymphocyte predominant Hodgkin's disease: Pathology and clinical implication, ANN ONCOL, 9, 1998, pp. 39-44

Authors: Harris, NL
Citation: Nl. Harris, The many faces of Hodgkin's disease around the world: What have we learnedfrom its pathology?, ANN ONCOL, 9, 1998, pp. 45-56

Authors: Cosset, JM Mauch, PM
Citation: Jm. Cosset et Pm. Mauch, The role of radiotherapy for early stage Hodgkin's disease: Limitations and perspectives, ANN ONCOL, 9, 1998, pp. 57-62

Authors: Noordijk, EM
Citation: Em. Noordijk, Radiotherapy in early stage Hodgkin's disease: Principles and results of recent clinical trials, ANN ONCOL, 9, 1998, pp. 63-65

Authors: Diehl, V Franklin, J Hasenclever, D Tesch, H Pfreundschuh, M Lathan, B Paulus, U Sieber, M Ruffer, JU Sextro, M Engert, A Wolf, J Hermann, R Holmer, L Stappert-Jahn, U Winnerlein-Trump, E Wulf, G Krause, S Glunz, A von Kalle, K Bischoff, H Haedicke, C Duhmke, E Georgii, A Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71

Authors: Loeffler, M Hasenclever, D Diehl, V
Citation: M. Loeffler et al., Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 73-78

Authors: Wolf, J Tesch, H Parsa-Parsi, R Engert, A Diehl, V
Citation: J. Wolf et al., Current clinical trials for the treatment of adult Hodgkin's disease: Common strategies and perspectives, ANN ONCOL, 9, 1998, pp. 79-82

Authors: Goldstone, AH
Citation: Ah. Goldstone, The case for and against high-dose therapy with stem cell rescue for earlypoor prognosis Hodgkin's disease in first remission, ANN ONCOL, 9, 1998, pp. 83-85

Authors: Hoppe, RT
Citation: Rt. Hoppe, Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 87-90

Authors: Canellos, GP
Citation: Gp. Canellos, Treatment of relapsed Hodgkin's disease: Strategies and prognostic factors, ANN ONCOL, 9, 1998, pp. 91-96

Authors: Horning, SJ
Citation: Sj. Horning, Primary refractory Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 97-101

Authors: Borchmann, P Schnell, R Diehl, V Engert, A
Citation: P. Borchmann et al., New drugs in the treatment of Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 103-108

Authors: Cavalli, F
Citation: F. Cavalli, Rare syndromes in Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 109-113

Authors: Schellong, G
Citation: G. Schellong, Pediatric Hodgkin's disease: Treatment in the late 1990s, ANN ONCOL, 9, 1998, pp. 115-119

Authors: Fisher, RI
Citation: Ri. Fisher, Treatment of grey zone lymphomas, ANN ONCOL, 9, 1998, pp. 121-123

Authors: Grunicke, HH
Citation: Hh. Grunicke, Molecular basis of targeted chemotherapy: Novel concepts with special reference to the treatment of Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 125-128

Authors: Rooney, CM Roskrow, MA Suzuki, N Ng, CLC Brenner, MK Heslop, H
Citation: Cm. Rooney et al., Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells, ANN ONCOL, 9, 1998, pp. 129-132

Authors: Armitage, JO
Citation: Jo. Armitage, Long-term toxicity of the treatment of Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 133-136

Authors: Kaasa, S Knobel, H Loge, JH
Citation: S. Kaasa et al., Hodgkin's disease: Quality of life in future trials, ANN ONCOL, 9, 1998, pp. 137-145
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>